Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2

Cell

Volumn 87, Issue 7, 1996, Pages 1181-1190

  Vikkula, Miikka ^a   Boon, Laurence M ^a,e   Carraway III, Kermit L ^b   Calvert, Jennifer T ^c   Diamonti, A John ^b   Goumnerov, Boyan ^a   Pasyk, Krystyna A ^d   Marchuk, Douglas A ^c   Warman, Matthew L ^a,f   Cantley, Lewis C ^b   Mulliken, John B ^a   Olsen, Bjorn R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROTEIN TYROSINE KINASE; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ANGIOGENESIS; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SEGREGATION; HUMAN; HUMAN CELL; MISSENSE MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VEIN MALFORMATION;

EID: 0030460775     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81814-0     Document Type: Article

References (46)

1. Allen, K.E., Varty, K., Jones, L., Sayers, R.D., Bell, P.R., and London, N.J. (1994). Human venous endothelium can promote intimai hyperplasia in a paracrine manner. J. Vase. Surg. 19, 577-584.
2. Antonelli-Orlidge, A., Saunders, K.B., Smith, S.R., and D'Amore, P.A. (1989). An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86, 4544-4548.
3. Bellus, G.A., Hefferon, T.W., Ortiz de Luna, R.I., Hecht, J.T., Horton, W.A., Machado, M., Kaitila, I., McIntosh, I., and Francomano, C.A. (1995). Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am. J. Hum. Genet. 56, 368-373.
4. Betsholtz, C. (1993). The PDGF genes and their regulation. In Biology of Platelet-Derived Growth Factor. Cytokines, B. Westermark and C. Sorg, eds. (Basel: Karger), pp. 11-30.
5. Bonin, L.R., and Damon, D.H. (1994). Vascular cell interactions modulate the expression of endothelin-1 and platelet-derived growth factor BB. Am. J. Physiol. 267, H1698-H1706.
6. Boon, L.M., Mulliken, J.B., Vikkula, M., Watkins, H., Seidman, J., Olsen, B.R., and Warman, M.L. (1994). Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum. Mol. Genet. 3, 1583-1587.
7. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
8. D'Amore, P.A., and Smith, S.R. (1993). Growth factor effects on cells of the vascular wall: a survey. Growth Factors 8, 61-75.
9. Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C., et al. (1996). Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, this issue.
10. Desmouliere, A., Geinoz, A., Gabbiani, F., and Gabbiani, G. (1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 722, 103-111.
11. Dumont, D.J., Anderson, L., Breitman, M.L., and Duncan, A.M. (1994). Assignment of the endothelial-specific protein receptor tyrosine kinase gene (TEK) to human chromosome 9p21. Genomics 23, 512-513.
12. Dumont, D.J., Gradwohl, G., Fong, G.H., Puri, M.C., Gertsenstein, M., Auerbach, A., and Breitman, M.L. (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes. Dev. 8, 1897-1909.
13. Dumont, D.J., Fong, G.H., Puri, M.C., Gradwohl, G., Alitalo, K., and Breitman, M.L. (1995). Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203, 80-92.
14. Fillinger, M.F., O'Connor, S.E., Wagner, R.J., and Cronenwett, J.L. (1993). The effect of endothelial cell coculture on smooth muscle cell proliferation. J. Vase. Surg. 17, 1058-1067.
15. Gallione, C.J., Pasyk, K.A., Boon, L.M., Lennon, F., Johnson, D.W., Helmbold, E.A., Markel, D.S., Vikkula, M., Mulliken, J.B., Warman, M.L., et al. (1995). A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J. Med. Genet. 32, 197-199.
16. Grotendorst, G.R., Seppa, H.E., Kleinman, H.K., and Martin, G.R. (1981). Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 78, 3669-3672.
17. Grotendorst, G.R., Chang, T., Seppa, H.E., Kleinman, H.K., and Martin, G.R. (1982). Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J. Cell. Physiol. 113, 261-266.
18. Guy, P.M., Carraway, K.L. III, and Cerione, R.A. (1992). Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases. J. Biol. Chem. 267, 13851-13856.
19. Holmgren, L., Glaser, A., Pfeifer-Ohlsson, S., and Ohlsson, R. (1991). Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development 113, 749-754.
20. Johnson, D.W., Berg, J.N., Baldwin, M.A., Gallione, C.J., Marondel, I., Yoon, S.J., Stenzel, T.T., Speer, M., Pericak-Vance, M.A., Diamond, A., et al. (1996). Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nature Genet. 13, 189-195.
21. Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V.W., Fang, G.H., Dumont, D., Breitman, M., and Alitalo, K. (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92, 3566-3570.
22. Kirby, M.L., and Waldo, K.L. (1995). Neural crest and cardiovascular patterning. Circ. Res. 77, 211-215.
23. Kraling, B.M., Razon, M.J., Boon, L.M., Zurakowski, D., Seachord, C., Darveau, R.P., Mulliken, J.B., Corless, C.L., and Bischoff, J. (1996). E-selectin is present in proliferating endothelial cells in human hemangiomas. Am. J. Pathol. 148, 1181-1191.
24. Levanat, S., Gorlin, R.J., Fallet, S., Johnson, D.R., Fantasia J.E., and Bale, A.E. (1996). A two-hit model for developmental defects in Gorlin syndrome. Nature Genet. 12, 85-87.
25. Leveen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E., and Betsholtz, C. (1994). Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8, 1875-1887.
26. McAllister, K.A., Grogg, K.M., Johnson, D.W., Gallione, C.J., Baldwin, M.A., Jackson, C.E., Helmbold, E.A., Markel, D.S., McKinnon, W.C., Murrell, J., et al. (1994). Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genet. 8, 345-351.
27. Merwin, J.R., Newman, W., Beall, L.D., Tucker, A., and Madri, J. (1991). Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro. Am. J. Pathol. 138, 37-51.
28. Mohammadi, M., Schlessinger, J., and Hubbard, S.R. (1996). Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86, 577-587.
29. Mulliken, J.B., and Young, A.E. (1988). Vascular birthmarks. In Hemangiomas and Malformations, J.B. Mulliken and A.E. Young, eds. (Philadelphia: W.B. Saunders).
30. Nakamura, H. (1988). Electron microscopic study of the prenatal development of the thoracic aorta in the rat. Am. J. Anat. 181, 406-418.
31. Naski, M.C., Wang, Q., Xu, J., and Ornitz, D.M. (1996). Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet. 13, 233-237.
32. Noden, D.M. (1989). Embryonic origins and assembly of blood vessels. Am. Rev. Respir. Dis. 140, 1097-1103.
33. Orlidge, A., and D'Amore, P.A. (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105, 1455-1462.
34. Powell, R.J., Carruth, J.A., Basson, M.D., Bloodgood, R., and Sumpio, B.E. (1996a). Matrix-specific effect of endothelial control of smooth muscle cell migration. J. Vasc. Surg. 24, 51-57.
35. Powell, R.J., Cronenwett, J.L., Fillinger, M.F., Wagner, R.J., and Sampson, L.N. (1996b). Endothelial cell modulation of smooth muscle cell morphology and organizational growth pattern. Ann. Vasc. Surg. 10, 4-10.
36. Risau, W., and Lemmon, V. (1988). Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol. 125, 441-450.
37. Risau, W., Sariola, H., Zerwes, H.G., Sasse, J., Ekblom, P., Kemler, R., and Doetschman, T. (1988). Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102, 471-478.
38. Sato, T.N., Tozawa, Y., Deutsch, U.,Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., and Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
39. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D.A., Smith, S., Uziel, T., Sfez, S., et al. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753.
40. Shah, N.M., Groves, A.K., and Anderson, D.J. (1996). Alternative neural crest cell fates are instructively promoted by TGFβ superfamily members. Cell 85, 331-343.
41. Shinbrot, E., Peters, K.G., and Williams, L.T. (1994). Expression of the platelet-derived growth factor beta receptor during organogenesis and tissue differentiation in the mouse embryo. Dev. Dyn. 199, 169-175.
42. Songyang, Z., Carraway, K.L., Eck, M.J., Harrison, S.C., Feldman, R.A., Mohammadi, M., Schlessinger, J., Hubbard, S.R., Smith, O.P., Eng, C., et al. (1995). Catalytic specificity of protein-tyrosine kinases is critical for selective signaling. Nature 373, 536-539.
43. Soriano, P. (1994). Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 8, 1888-1896.
44. Takahashi, K., Mulliken, J.B., Kozakewich, H.P., Rogers, R.A., Folkman, J., and Ezekowitz, R.A. (1994). Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J. Clin. Invest. 93, 2357-2364.
45. Webster, M.K., d'Avis, P.Y., Robertson, S.C., and Donoghue, D.J. (1996). Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol. 16, 4081-4087.
46. Westermark, B., Siegbahn, A., Heldin, C.H., and Claesson-Welsh, L. (1990). B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. Proc. Natl. Acad. Sci. USA 87, 128-132.